PXMD PaxMedica
- 0.688
- -0.057-7.61%
- 0.388
- -0.301-43.67%
PaxMedica News
PaxMedica | 8-K: Current report
PaxMedica | 8-K: PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
PaxMedica | 8-K: PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
PaxMedica | ARS: Annual Report to Security Holders
PaxMedica | DEF 14A: Definitive information statements
PaxMedica | 8-K: PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
PaxMedica | PRE 14A: Preliminary proxy statements relating to merger or acquisition
PaxMedica | 8-K: Current report
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Officer Weisman Howard J.
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Officer Sheldon Stephen
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Director Coelho John F
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Officer Hough David W.
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Director LaRochelle Karen
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Director Rome Zachary
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Director CASAMENTO CHARLES J
PaxMedica | 8-K: PaxMedica Releases Updated Company Profile Presentation
PaxMedica | 10-K: Annual report
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Officer Sheldon Stephen
PaxMedica | 4: Statement of changes in beneficial ownership of securities-Officer Hough David W.
PaxMedica | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Analysis
Price Target
No Data
